|
(MoneyNewsWire.Net, November 21, 2017 ) According to the report Europe Antivenom Market, published by Market DataForecast, the global market is projected to reach USD 340.3 million by 2021, at a CAGR of 5.21% from 2016 to 2021.
Get accurate market forecast and analysis on the Europe AntivenomMarket. Request a sample to stay up-to-date on the main trends affecting this market http://www.marketdataforecast.com/market-reports/europe-antivenom-market-1582/request-sample
Antivenomis described as the biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that, approximately 15,000-20,000 people die with snake bites annually in Europe.
To overcome poisonous effects after venomous bites the manufacturers developed number of Antivenom products including vaccines and hyperimmune sera.This has been due to a combination of factors, including Inadequate investment by governments and non-government organisations, High manufacturing costs and inefficient production processes, Inconsistent quality standards; andInappropriate clinical application.
Europe AntivenomMarket: Drivers & Restraints
Growing involvement of research institutes to support the development of effective antivenom products, existence of established medical care system, and development of effective antivenom products against multiple venomous animals are driving the growth Europe Antivenom Market. However, stringent regulatories, high cost of the products, and limited accessibility of antivenom products are restraining the growth Europe Antivenom Market.
Get a comprehensive overview of the Europe Antivenom Market: http://www.marketdataforecast.com/market-reports/europe-antivenom-market-1582/
Europe AntivenomMarket: Segmentation
ByType
• Introduction
• Vaccines
• Hyperimmune Sera
o Homologous
o Heterologous
• Y-o-Y Growth Analysis, By type
• Market Attractiveness Analysis, By Type
• Market Share Analysis, By Type
By Animal
• Introduction
• Snakes
• Scorpions
• Spiders
• Others
• Y-o-Y Growth Analysis, By Animal
• Market Attractiveness Analysis, By Animal
• Market Share Analysis, By Animal
Fromsimple data collation through secondary and primary research toad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/europe-antivenom-market-1582/customize-report
Europe AntivenomMarket: Overview
As discussed earlier, Snake bite is a neglected public health issue in many tropical and subtropical countries. About 5 million snake bites occur each year, resulting in up to 2.5 million envenoming’s (poisoning from snake bites), at least 100 000 deaths and around three times as many amputations and other permanent disabilities. Recent studies of pharmacokinetics of envenoming permitted improved understanding of immunotherapy. Improved purification of the antivenom by using immunoglobulin fragments has led to increased tolerance and efficiency of antivenoms. The immunisation procedures and purification and use of IgG fragments for use in antivenoms development can be improved further using modern technology.
Europe AntivenomMarket: Region-wise Outlook
Geographically, Europe Antivenom market is segmented into United Kingdom, Germany, France, Italy, and Spain.North America follows Europe in terms of the size of the excipients market, accounting for almost 2/3 of the revenue. The revenue from the market in Europe is expected to expand at a healthy CAGR of 6.1% over the forecast period despite the ongoing economic downturn in the region.
Key Questions Answered
• What is the current and future Antivenommarket outlook in Europe? What trends are affecting the Europe market?
• What is the competitive landscape and market share of major players in the Antivenomspace in Europe?
• What are the key, high growth markets that Antivenommanufacturers should expand into? Which market segments are growing the fastest?
• What are the unmet needs with the Antivenomcurrently on the market? How will emerging technologies fulfil these unmet needs?
• What is physician perception and market outlook of Antivenom?
• What are the challenges and barriers that have hindered widespread adoption of Antivenom?
Europe AntivenomMarket: Key Players
Key market players in the Antivenom market include InstitutoBioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), VinsBioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India).
Reasons to buy Europe AntivenomMarket Report:
•Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
• Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
•Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
•Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
•A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
•Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
•Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
Europe Regenerative Medicines Market: http://www.marketdataforecast.com/market-reports/europe-regenerative-medicines-market-274/
Europe Biosimilars Market: http://www.marketdataforecast.com/market-reports/europe-biosimilars-market-1144/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
